These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9569775)

  • 21. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
    Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
    J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
    Xie B; Wainberg MA; Frankel AD
    J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR.
    Gatignol A; Buckler-White A; Berkhout B; Jeang KT
    Science; 1991 Mar; 251(5001):1597-600. PubMed ID: 2011739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
    Gatignol A; Duarte M; Daviet L; Chang YN; Jeang KT
    Gene Expr; 1996; 5(4-5):217-28. PubMed ID: 8723388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription.
    Wang W; Guo Z; Chen Y; Liu T; Jiang L
    Chem Biol Drug Des; 2006 Dec; 68(6):314-8. PubMed ID: 17177893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS; Madore SJ; Malim MH; Cullen BR
    Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective binding of TAR RNA by a Tat-derived beta-peptide.
    Gelman MA; Richter S; Cao H; Umezawa N; Gellman SH; Rana TM
    Org Lett; 2003 Oct; 5(20):3563-5. PubMed ID: 14507173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
    Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
    J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
    Endo-Munoz L; Warby T; Harrich D; McMillan NA
    Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.
    Taylor JP; Kundu M; Khalili K
    Virology; 1993 Aug; 195(2):780-5. PubMed ID: 8337844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z; Huq I; Rana TM
    Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex.
    Keen NJ; Gait MJ; Karn J
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2505-10. PubMed ID: 8637904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of a cyclic BIV beta-Tat peptide with its TAR RNA construct.
    Tok JB; Des Jean RC; Fenker J
    Bioorg Med Chem Lett; 2001 Jan; 11(1):43-6. PubMed ID: 11140729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.